Modular Medical, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Philip Brent Sheibley, a Director at Modular Medical, Inc., acquired 250 stock options on June 30, 2026, under the company's Outside Director Compensation Plan.
NASDAQ
Duane M. DeSisto, a Director at Modular Medical, Inc., acquired 83 shares of common stock on June 30, 2026, under the company's Outside Director Compensation Plan.
NASDAQ
Director Frank Morgan C. acquired options to purchase 312 shares of Modular Medical, Inc. (MODD) under the company's Outside Director Compensation Plan.
NASDAQ
Paul DiPerna, Chairman, President, and CFO of Modular Medical, was granted 11,218 stock options.
NASDAQ
Modular Medical, Inc. Chief Operating Officer Kevin Schmid was granted 4,674 stock options as part of an equity incentive.
NASDAQ
Director Frank Morgan C. reports acquisition of stock options in Modular Medical, Inc. (MODD) under the company's Outside Director Compensation Plan.
NASDAQ
Ellen O'Connor Vos, a Director at Modular Medical, Inc., acquired stock options as part of the company's Outside Director Compensation Plan.
NASDAQ
Jeff D. Goldberg, a Director at Modular Medical, Inc., acquired stock options under the company's Outside Director Compensation Plan.
NASDAQ
Philip Brent Sheibley, a Director at Modular Medical, Inc., acquired stock options through the company's Outside Director Compensation Plan.
NASDAQ
Steven G. Felsher, a Director at Modular Medical, Inc., reported the acquisition of 25 shares of common stock on March 31, 2026, as part of the company's Outside Director Compensation Plan.
NASDAQ
Duane M. DeSisto, a Director at Modular Medical, Inc., acquired 83 shares of common stock on March 31, 2026, under the company's Outside Director Compensation Plan.
NASDAQ
Carmen B. Volkart, a Director at Modular Medical, Inc., reported a transaction involving the acquisition of common stock.
NASDAQ
Modular Medical Director Duane M. DeSisto acquired 2,500 shares of common stock through the company's director compensation plan, increasing his direct beneficial ownership to 274,890 shares.
NASDAQ
Modular Medical, Inc. Director Ellen O'Connor Vos received a grant of 7,500 stock options, fully vested and exercisable at $0.36 per share.
NASDAQ
Modular Medical, Inc. Director Philip Sheibley acquired 7,500 stock options at an exercise price of $0.36, fully vested on the grant date.
NASDAQ
Modular Medical, Inc. director Jeff D. Goldberg was granted 7,500 stock options at an exercise price of $0.36, fully vested upon grant.
NASDAQ
Modular Medical Director Steven G. Felsher acquired 750 shares of common stock and 7,500 stock options as part of the company's Outside Director Compensation Plan.
NASDAQ
Modular Medical Director Carmen B Volkart plans to acquire 3,125 shares of common stock on December 31, 2025, increasing her direct beneficial ownership to 21,460 shares.
NASDAQ
Modular Medical Director Morgan C. Frank acquired options to purchase common stock, fully vested and exercisable on the grant date, as part of the company's director compensation plan.
NASDAQ
Modular Medical Director Steven G. Felsher acquired 60,000 shares of common stock and warrants for 30,000 shares in a public offering.
NASDAQ
A director at Modular Medical, Inc. acquired 60,000 shares of common stock and warrants for 30,000 shares in a recent public offering.
NASDAQ
Modular Medical Director Morgan C. Frank acquired 9,375 stock options at an exercise price of $0.70, fully vested upon grant.
NASDAQ
Modular Medical Director Jeff D. Goldberg received 7,500 stock options at an exercise price of $0.7, fully vested upon grant, aligning his interests with shareholders.
NASDAQ
Modular Medical, Inc. Director Ellen O'Connor Vos was granted 7,500 stock options at an exercise price of $0.70, fully vested on September 30, 2025.
NASDAQ
Modular Medical, Inc. Director Philip Brent Sheibley was granted 7,500 stock options at an exercise price of $0.7, fully vested on September 30, 2025.
NASDAQ
Modular Medical Director Steven G. Felsher acquired 750 shares of common stock and 7,500 stock options as part of the company's director compensation plan.
NASDAQ
Modular Medical Director Duane M. DeSisto acquired 2,500 shares of common stock as part of his compensation plan, increasing his total beneficial ownership to 272,390 shares.
NASDAQ
Modular Medical Director Carmen Volkart acquired 3,125 shares of common stock, increasing her beneficial ownership to 18,335 shares.
NASDAQ
Modular Medical, Inc. Director and 10% Owner, Morgan C. Frank, was granted a total of 9,375 stock options at an exercise price of $0.68 per share, fully vested upon grant.
NASDAQ
Modular Medical, Inc. Director Ellen O'Connor Vos was granted 7,500 options to purchase common stock at an exercise price of $0.68, fully vested and exercisable on the grant date of June 30, 2025.